Replies to post #111819 on Biotech Values

[DewDiligence]

…Teva’s CFO said the company is looking for big branded acquisitions in the range of $2B-$8B, in cancer, neurology and immunology arenas.

In hindsight, CEPH is an obvious fit with those specifications.